Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

JOHNSON & JOHNSON Director's Dealing 2022

Jun 15, 2022

29750_dirs_2022-06-14_dd42e718-0587-4e02-aea7-32fbaaf4202e.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: JOHNSON & JOHNSON (JNJ)
CIK: 0000200406
Period of Report: 2022-06-10

Reporting Person: Wengel Kathryn E (EVP, Chief GSC Officer)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2022-06-10 Common Stock M 40000.0000 $72.5400 Acquired 111310.8735 Direct
2022-06-10 Common Stock S 100.0000 $173.0010 Disposed 111210.8735 Direct
2022-06-10 Common Stock S 174.0000 $173.0010 Disposed 111036.8735 Direct
2022-06-10 Common Stock S 6600.0000 $173.0010 Disposed 104436.8735 Direct
2022-06-10 Common Stock S 33126.0000 $173.0010 Disposed 71310.8735 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2022-06-10 Employee Stock Options (Right to Buy) $72.5400 M 40000.0000 Disposed 2023-01-13 Common Stock (40000.0000) Direct

Holdings (Non-Derivative)

Security Shares Ownership
Common Stock 50.0000 Indirect
Common Stock 281.0000 Indirect

Footnotes

F1: This transaction was executed in multiple trades at prices ranging from 173.00 to 173.02 . The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide, upon request, to the SEC staff, the issuer, or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

F2: Includes shares accrued due to dividend reinvestment in the Johnson & Johnson Stock Fund under the Johnson & Johnson Savings Plan as of the Plan's most recent reporting date (5/31/2022)

F3: Shares held by ESOP under the Johnson & Johnson Savings Plan as of the Plan's most recent reporting date (5/31/2022)